IL150048A0 - Enzyme treatment for infection - Google Patents

Enzyme treatment for infection

Info

Publication number
IL150048A0
IL150048A0 IL15004800A IL15004800A IL150048A0 IL 150048 A0 IL150048 A0 IL 150048A0 IL 15004800 A IL15004800 A IL 15004800A IL 15004800 A IL15004800 A IL 15004800A IL 150048 A0 IL150048 A0 IL 150048A0
Authority
IL
Israel
Prior art keywords
infection
enzyme treatment
enzyme
treatment
Prior art date
Application number
IL15004800A
Other languages
English (en)
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150048(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of IL150048A0 publication Critical patent/IL150048A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL15004800A 1999-12-10 2000-12-08 Enzyme treatment for infection IL150048A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10
PCT/US2000/033466 WO2001041785A2 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection

Publications (1)

Publication Number Publication Date
IL150048A0 true IL150048A0 (en) 2002-12-01

Family

ID=22617824

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15004800A IL150048A0 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Country Status (31)

Country Link
US (2) US6780628B2 (enExample)
EP (1) EP1239872B1 (enExample)
JP (1) JP4871473B2 (enExample)
KR (1) KR100639746B1 (enExample)
CN (3) CN101327320A (enExample)
AR (2) AR026764A1 (enExample)
AT (1) ATE481981T1 (enExample)
AU (1) AU782831B2 (enExample)
BR (1) BRPI0016231B8 (enExample)
CA (1) CA2394856C (enExample)
CL (1) CL2008000057A1 (enExample)
CO (1) CO5280226A1 (enExample)
CR (1) CR6674A (enExample)
CZ (1) CZ304925B6 (enExample)
DE (1) DE60045010D1 (enExample)
DK (1) DK1239872T3 (enExample)
ES (1) ES2353371T3 (enExample)
HU (1) HU230301B1 (enExample)
IL (2) IL150048A0 (enExample)
IN (1) IN247731B (enExample)
MX (1) MX264033B (enExample)
MY (1) MY124714A (enExample)
NZ (1) NZ519404A (enExample)
PH (1) PH12000003381B1 (enExample)
PL (1) PL203054B1 (enExample)
PT (1) PT1239872E (enExample)
RU (1) RU2272419C2 (enExample)
SK (1) SK287956B6 (enExample)
TW (1) TWI255189B (enExample)
UA (1) UA78486C2 (enExample)
WO (1) WO2001041785A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
WO2006130034A1 (fr) 2005-04-25 2006-12-07 Dmitry Dmitrievich Genkin Procede pour prolonger la duree de vie d'animaux ou de l'humain
US20080274095A1 (en) * 2004-10-20 2008-11-06 Jane Homan Biocides
GT200600512A (es) * 2005-12-15 2007-06-28 Enzimas para reducir el estres inmunologico
BRPI0707207A2 (pt) * 2006-01-23 2011-04-26 Hills Pet Nutrition Inc métodos para reduzir a ingestão de ração por um animal, e para controlar o peso de um animal, kit, meio para comunicar informação ou instruções sobre a alimentação em um animal, artigo de fabricação, ração, e, uso da ração
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
EP2095825B8 (en) 2006-11-28 2012-03-28 CLS Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
MX2009012924A (es) * 2007-06-08 2010-03-25 Australian Poultry Crc Pty Ltd Toxina clostridial netb.
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
AU2008343325B2 (en) * 2007-12-20 2013-08-15 Danisco Us Inc. Enzymatic prevention and control of biofilm
NO2254591T3 (enExample) 2008-02-08 2017-12-23
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
EP2814331B1 (en) 2012-02-16 2018-12-05 Elanco US Inc. Methods and compositions for reducing the environmental impact of animal waste
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
RU2726131C2 (ru) 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Внеклеточная днк в качестве терапевтической мишени при нейродегенерации
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
EP3740581A4 (en) 2018-01-16 2021-10-27 CLS Therapeutics Limited TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY
KR20200128413A (ko) * 2018-03-02 2020-11-12 에보니크 오퍼레이션즈 게엠베하 오보트랜스페린을 결정함으로써 동물에서의 장 장벽 기능상실을 검출하기 위한 시험관내 방법
BR112021011158A2 (pt) 2018-12-14 2021-08-31 Evonik Operations Gmbh Método in vitro para detectar disbiose intestinal aviária, uso do dito método e uso de isoleucil-arginina ou isômeros desta
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
JPH0779694B2 (ja) 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
DK0531437T3 (da) 1990-05-29 1998-08-31 Chemgen Corp Hemicellulasetilskud med henblik på at forbedre energiudnyttelsen af hemicelluloseholdige levnedsmidler og dyrefoder
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
RU2113220C1 (ru) * 1991-07-24 1998-06-20 Энзакор Пропертиз Лимитед Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
CN1092495C (zh) * 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
JP2001504327A (ja) * 1996-10-31 2001-04-03 ノボ ノルディスク アクティーゼルスカブ 新規ホスホリパーゼ、その生産及び使用
KR20010089301A (ko) * 1998-10-15 2001-09-29 윌리암 로엘프 드 보에르 동물 사료에서 항미생물 효소
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116028A1 (en) * 2001-02-20 2002-08-22 Wilson Greatbatch MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality

Also Published As

Publication number Publication date
TWI255189B (en) 2006-05-21
SK287956B6 (sk) 2012-07-03
WO2001041785A3 (en) 2002-01-24
BR0016231A (pt) 2003-06-24
CN102172262B (zh) 2014-03-05
KR20020069204A (ko) 2002-08-29
SK8262002A3 (en) 2002-12-03
MX264033B (es) 2009-01-22
WO2001041785A2 (en) 2001-06-14
IL150048A (en) 2016-09-29
AU782831B2 (en) 2005-09-01
MY124714A (en) 2006-06-30
CN1433319A (zh) 2003-07-30
EP1239872B1 (en) 2010-09-22
HU230301B1 (hu) 2015-12-28
CN102172262A (zh) 2011-09-07
IN2002DE00585A (enExample) 2009-03-20
HUP0203402A3 (en) 2004-12-28
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
US20040223961A1 (en) 2004-11-11
CZ20022007A3 (cs) 2002-11-13
AR089799A2 (es) 2014-09-17
AU2577601A (en) 2001-06-18
RU2272419C2 (ru) 2006-03-27
DE60045010D1 (de) 2010-11-04
US7723091B2 (en) 2010-05-25
JP4871473B2 (ja) 2012-02-08
NZ519404A (en) 2004-05-28
CR6674A (es) 2007-02-22
DK1239872T3 (da) 2010-10-25
ATE481981T1 (de) 2010-10-15
BRPI0016231B8 (pt) 2021-05-25
PT1239872E (pt) 2010-12-03
HUP0203402A2 (hu) 2003-02-28
EP1239872A2 (en) 2002-09-18
JP2003520207A (ja) 2003-07-02
PL356175A1 (en) 2004-06-14
UA78486C2 (uk) 2007-04-10
IN247731B (enExample) 2011-05-13
US6780628B2 (en) 2004-08-24
US20020048576A1 (en) 2002-04-25
CN101327320A (zh) 2008-12-24
CL2008000057A1 (es) 2008-03-14
BRPI0016231B1 (pt) 2016-10-04
CO5280226A1 (es) 2003-05-30
CA2394856A1 (en) 2001-06-14
CZ304925B6 (cs) 2015-01-28
PH12000003381B1 (en) 2010-04-16
ES2353371T3 (es) 2011-03-01
KR100639746B1 (ko) 2006-10-30
MXPA02005735A (es) 2003-10-14
PL203054B1 (pl) 2009-08-31

Similar Documents

Publication Publication Date Title
PH12000003381B1 (en) Enzyme treatment for infection
GB9928968D0 (en) Enzyme
IL146255A0 (en) Attenuated microorganisms for the treatment of infection
ZA200108446B (en) Novel method of treatment.
AU5547000A (en) Novel treatment
AU5215300A (en) Dental treatment area
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AU4556800A (en) Novel treatment
GB9906245D0 (en) Enzyme
AU5639700A (en) Targeted anticalcification treatment
AU1972200A (en) Treatment for fabrics
GB9924634D0 (en) Enzyme
GB9908458D0 (en) Enzyme
GB9908993D0 (en) Treatment
GB9920787D0 (en) Novel treatment
GB9909650D0 (en) Novel treatment
GB9916655D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB9923343D0 (en) Treatment system
ZA200002170B (en) Treatment of acarids.
GB9903558D0 (en) Medical treatment
GB9923111D0 (en) Effluent treatment
AUPQ281499A0 (en) Treatment mat
GB9924583D0 (en) Sludge treatment